Lung cancer, Non small cell lung cancer (NSCLC), Small cell lung cancer
Results
Other
This study looked at blood samples and scans of people who had radiotherapy for lung cancer.
After having radiotherapy for lung cancer you usually have a number of CT scans. By measuring changes in the size and shape of the cancer in these scans, your doctor may be able to tell how well the treatment has worked.
Researchers wanted to develop better tests to predict how well radiotherapy might work. And to find out who is more likely to have side effects.
They looked at and proteins (called ) in the blood and cancer tissue of people who had radiotherapy for lung cancer. They also used PET-CT scans to look at how radiotherapy affected the healthy and lung cancer tissue.
The main aims of this study were to develop better tests to:
work out in advance who would benefit from having radiotherapy
see who is at greatest risk of side effects
The study was open for people to join between 2010 and 2012. The team published the results in 2018.
Recruitment start: 1 March 2010
Recruitment end: 31 January 2012
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Fiona Blackhall Professor Corinne Faivre Finn
AstraZeneca
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
The Christie Lung Cancer Research Fund
Last reviewed: 27 February 2024
CRUK internal database number: 5933